Trade IDYA anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
IDEAYA Biosciences, Inc. (IDYA) is trading at US$40.11, down 3.97% today as of Aug 28, 16:00 EDT. The company has a market capitalisation of US$3.83B. Over the past 52 weeks, IDYA has traded between US$23.23 and US$42.68. On Syfe you can trade IDYA with $0 commission and add it to your watchlist.
| Previous close | US$41.77 |
|---|---|
| Market cap | US$3.83B |
| 52-week range | US$23.23 – US$42.68 |
| Volume | 712.89K |
| Exchange | US |
Add to Watchlist
Set Price Alert
IDEAYA Biosciences, Inc.
IDEAYA Biosciences, Inc. engages in the research and development of oncology-focused precision medicine. The firm focuses on the targeted therapeutics for patients selected using molecular diagnostics. Its product candidate, IDE196, is a protein kinase C inhibitor for genetically defined cancers having GNAQ and GNA11 gene mutations. The company was founded by Yujiro S. Hata and Jeffrey Hager in June 2015 and is headquartered in South San Francisco, CA.
Year: 2019
IDEAYA Biosciences, Inc. (IDYA) stock is trading at US$40.11, -3.97% from the previous close of US$41.77.
The market cap for IDEAYA Biosciences, Inc. (IDYA) stock is approximately US$3.83B.
The 52-week high for IDEAYA Biosciences, Inc. (IDYA) stock is US$42.68.
The 52-week low for IDEAYA Biosciences, Inc. (IDYA) stock is US$23.23.
IDEAYA Biosciences, Inc. (IDYA) does not currently pay a dividend.
Stay on top of IDYA
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
